• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CordovaCann to Acquire Cannabis Retail License in Ontario

Share:

April 20, 2020

CordovaCann (OTCQB:LVRLF) has entered into a letter of intent to purchase a 50.1% stake of 2734158 Ontario Inc., for C$723k.

2734158 Ontario Inc., is an Ontario-based cannabis venture with a cannabis retail operating license from the Alcohol and Gaming Commission of Ontario.

This transaction will enable Cordova to open five recreational cannabis stores in Ontario under the Starbuds brand, and further gives Cordova the right to apply to open a total of 75 stores in the province over the next year and a half.

The Transaction is subject to prior approval from the Alcohol and Gaming Commission of Ontario and compliance with all applicable laws, rules and regulations.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Seeking Alpha

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Experity Acquires Teleradiology PACS Platform OnePACSExperity Acquires Teleradiology PACS Platform OnePACS
  • Nona Biosciences Announces Business Update of Collaboration on Antibody Drug Conjugate (ADC) with DualityBioNona Biosciences Announces Business Update of Collaboration on Antibody Drug Conjugate (ADC) with DualityBio
  • Senhwa Biosciences Received Taiwan FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral InfectionSenhwa Biosciences Received Taiwan FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection
  • Functional Dyspepsia Market to Exhibit Substantial Growth During the Forecast Period (2019- 2032) | Key Companies -Zeria Pharma, Raqualia Pharma, Isothrive, and Jiangxi Qingfeng PharmaFunctional Dyspepsia Market to Exhibit Substantial Growth During the Forecast Period (2019- 2032) | Key Companies -Zeria Pharma, Raqualia Pharma, Isothrive, and Jiangxi Qingfeng Pharma
  • Kaia Health Teams with Chiesi Group to Commercialise COPD App in EuropeKaia Health Teams with Chiesi Group to Commercialise COPD App in Europe
  • Boston Scientific Closes Acquisition Of BTG plc.Boston Scientific Closes Acquisition Of BTG plc.
  • Do We Know When Medical Devices Fail?Do We Know When Medical Devices Fail?
  • Doccla Acquires OpenTeleHealth, Expanding in 12 MarketsDoccla Acquires OpenTeleHealth, Expanding in 12 Markets

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications